1995
In Vivo D2 Dopamine Receptor Density in Psychotic and Nonpsychotic Patients With Bipolar Disorder
Pearlson G, Wong D, Tune L, Ross C, Chase G, Links J, Dannals R, Wilson A, Ravert H, Wagner H, DePaulo J. In Vivo D2 Dopamine Receptor Density in Psychotic and Nonpsychotic Patients With Bipolar Disorder. JAMA Psychiatry 1995, 52: 471-477. PMID: 7771917, DOI: 10.1001/archpsyc.1995.03950180057008.Peer-Reviewed Original ResearchConceptsSchizophrenic patientsBipolar disorderBmax valuesNonpsychotic patientsNormal controlsPsychotic symptomsPsychotic patientsAffective disordersPositron emission tomographic scansD2 dopamine receptor densityNeuroleptic-naive schizophrenic patientsPositron emission tomographic studiesDopamine receptor densityReceptor density valuesDSM-III criteriaPresent State ExaminationPresence of psychosisEmission tomographic studiesHigher Bmax valuesPsychotic bipolar disorderNeuroleptic medicationReceptor BmaxMood abnormalitiesReceptor valuesTomographic scan
1994
Late onset paranoid disorders:
Arie T, Almeida O, Howard R, Förstl H, Levy R, Rabins P, Pearlson G. Late onset paranoid disorders:. 1994, 303-325. DOI: 10.1017/cbo9780511526756.020.Peer-Reviewed Original ResearchLate paraphreniaDementia praecoxDiagnostic categoriesOrganic mental disordersBasic clinical featuresDiagnosis of schizophreniaMarked delusionsClinical featuresPsychotic symptomsCurrent psychiatric nosologyDelusional disorderMental disordersParaphreniaPatientsMiddle lifeLater lifeParanoid patientsRecent evidenceDiagnosisHallucinationsDisordersDelusionsPsychiatric nosologyEmil KraepelinParaphrenics
1988
D2 DOPAMINE RECEPTORS IN TOURETTE'S SYNDROME AND MANIC DEPRESSIVE ILLNESS
Wong D, Singer H, Pearlson G, Tune L, Ross C, Villemagne V, Dannals R, Links J, Wilson A, Ravert H, Wagner H, Gjedde A. D2 DOPAMINE RECEPTORS IN TOURETTE'S SYNDROME AND MANIC DEPRESSIVE ILLNESS. Clinical Nuclear Medicine 1988, 13: 392. DOI: 10.1097/00003072-198805000-00040.Peer-Reviewed Original ResearchManic-depressive illnessTourette syndromeDepressive illnessPsychotic symptomsD2 dopamine receptor densityDrug-free patientsDopamine receptor densityGreater clinical severityD2 dopamine receptorsOral haloperidolFree patientsMotor abnormalitiesAntagonist haloperidolClinical severityTourette patientsDopamine receptorsReceptor densityParkinson's diseaseCommon treatmentPsychiatric disordersActive psychosisSyndromePatientsAdult subjectsBmax values